European Journal of Cancer Supplements, 1359-6349

Tidskrift

Fler filtreringsmöjligheter
  1. Publicerat konferensabstract
  2. A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer

    S Margolin, L Carlsson, M Hellström, P Karlsson, E Lidbrink, B Linderholm, H Lindman, Per Malmström, D Sköld Pettersson & J Bergh, 2008, I: European Journal of Cancer Supplements. 6, 7, s. 116-117

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  3. Systematic validation of novel breast cancer progression-associated biomarkers via high-throughput antibody generation and application of tissue microarray technology

    S A Penny, C M Kelly, D J Brennan, A C Culhane, D G Higgins, P A Dervan, Karin Jirström, F Ponten, M Uhlen & W M Gallagher, 2008, I: European Journal of Cancer Supplements. 6, 7, s. 59-59

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Föregående 1 2 Nästa